NAVROZE MEHTA, FOUNDER

2011_DIG_Head_Shots-4-2 pic2

Navroze is Founder and CEO of New Day Diagnostics.   Two initial areas of focus of the company are point of care diagnostic markers for Ovarian and Prostate cancer.  He is also Founder and CEO of Impact Medical Strategies. Impact Medical Strategies is dedicated to promoting technologies that can solve major global medical unmet needs. Its goal is to make widely applicable devices and health care services sustainable, affordable and accessible to all.  Navroze Mehta is also Founder & CEO of Mela Artisans Inc. (www.melaartisans.com). He co-founded Mela with his daughter Sonali Mehta Rao. Mela Artisans blends traditional handcrafting techniques with contemporary design in home and fashion to promote social uplift in artisan communities.

 Navroze received an MBA from Syracuse University and a Bachelor of Commerce degree from Sydenham College at the University of Bombay, India. Navroze has been a member of Young Presidents Organization (YPO) for 20 years, is past chair of the Americas Gateway Chapter, and served as Regional Chair of the Economic Development Network. He is also a past member of the Ashoka Support Network (www.ashoka.org), a leader in the field of social entrepreneurship and has invested in several social impact enterprises.

PREM GURNANI, CHIEF SCIENTIFIC OFFICER

Prem Gurnani, Chief Scientific Officer at Ovation Diagnostics LLC has over 15 years of expert proficiency in new product development, clinical laboratory setup, operations and management, reimbursement and payor strategy, and health information technology. He started his career at PerkinElmer, Inc. where he was a leading scientist in the Genetic Screening R&D group that was responsible for successful FDA approval of two newborn screening tests. He then moved to Houston, Texas to start a personalized genetics company, CompanionDx Reference Lab, where he served in various executive positions.  Since then, he has helped open three genetics and proteomics clinical labs – InSource Diagnostics, Altru Diagnostics, Inc., and UT Health Science Center where he held senior executive management positions in operations, technology, strategy development and R&D.

Prem currently serves as a consultant for several diagnostics labs and healthcare technology companies. He has authored over 50 publications, including abstracts, posters, presentations, and books. He has also co-authored and served as a co-investigator in multiple grants.

Prem earned his MS in Biomedical Engineering from UTSW Medical Center, Dallas/ UT, Arlington, and extended his education with The Wharton Business School and John Hopkins Bloomberg School of Public Health.